Hee Eun Kang
Overview
Explore the profile of Hee Eun Kang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
384
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim J, Baek E, Kang H
Xenobiotica
. 2024 Sep;
54(9):723-729.
PMID: 39264043
Various pharmacokinetic changes have been reported in experimental hyperlipidemic (HL) animal models. To evaluate whether P-glycoprotein (P-gp) activity was affected in HL rats, we assessed the pharmacokinetics of dabigatran after...
2.
Lee D, Kang H
Xenobiotica
. 2023 Sep;
53(5):438-444.
PMID: 37737842
The pharmacokinetics of a new 5-hydroxytryptamine receptor 4 agonist, DA-6886, intended for the treatment of constipation-predominant irritable bowel syndrome, were evaluated in beagle dogs following both intravenous and oral administration...
3.
Kang H, Kim S, Yeo E, Hong J, Rajgopal A, Hu C, et al.
Nutrients
. 2022 Aug;
14(15).
PMID: 35956389
Glucosamine and chondroitin sulfate have been used as nutritional supplementation for joint tissues and osteoarthritis (OA). Biofermented glucosamine is of great interest in the supplement industry as an alternative source...
4.
Lee D, Kang H
Pharmaceutics
. 2022 Apr;
14(4).
PMID: 35456538
DA-6886 is a novel serotonin (5-hydroxytrypamine [5-HT]) receptor 4 agonist for the potential treatment of constipation-predominant irritable bowel syndrome. The purpose of this study was to validate the quantitative assay...
5.
Kang H, Seo Y, Yun J, Song S, Han D, Cho E, et al.
Cancers (Basel)
. 2021 Jul;
13(14).
PMID: 34298652
The Wnt and Hippo pathways are tightly coordinated and understanding their reciprocal regulation may provide a novel therapeutic strategy for cancer. Anti-helminthic niclosamide is an effective inhibitor of Wnt and...
6.
Jeong H, Lee S, Kang H
Fundam Clin Pharmacol
. 2021 Apr;
35(6):1100-1108.
PMID: 33914974
Background & Objectives: Upregulation of hepatic P-glycoprotein (P-gp) expression has been reported in patients with non-alcoholic fatty liver disease (NAFLD) and rodent models thereof. Here, we explored the changes hepatic...
7.
Kwon M, Lee D, Kang H
Pharmaceuticals (Basel)
. 2021 Mar;
14(2).
PMID: 33670597
DA-7010 is a new candidate for an antibacterial agent that targets Gram-negative pathogens by acting as a leucyl-tRNA synthetase inhibitor. In this study, a simple and rapid liquid chromatography tandem...
8.
Li Z, Lee S, Jeong H, Kang H
Xenobiotica
. 2020 Nov;
51(3):324-334.
PMID: 33185134
Impaired oxidation of clozapine has been reported in steatotic rat liver due to downregulation of cytochrome P450 (CYP) 1A. Pharmacokinetic changes of clozapine and its major metabolite, norclozapine, were evaluated...
9.
Kim K, Kang H, In Yook J, Yu H, Kim E, Cha J, et al.
J Clin Med
. 2020 Feb;
9(2).
PMID: 32012982
This study was performed to investigate the changes in gene expression in periodontal ligament (PDL) cells following mechanical stimulus through RNA sequencing. In this study, premolars extracted for orthodontic treatment...
10.
Subali D, Kwon M, Bang W, Kang H
Can J Physiol Pharmacol
. 2019 Oct;
98(3):169-176.
PMID: 31652406
Post-transplantation nonalcoholic fatty liver disease (NAFLD) is common in liver transplant recipients. Changes in the expression levels and activities of drug-metabolizing enzymes and drug transporters have been reported in patients...